Expertise in
44
conditions

Dr. Frederic B. Newman

Gastroenterology
5147 N 9th Ave, Ste 311, 
Pensacola, FL 
Accepting New Patients
Expertise in
44
conditions
5147 N 9th Ave, Ste 311, 
Pensacola, FL 

Overview

Frederic B. Newman, MD, is an independent gastroenterologist at Ascension Sacred Heart in Pensacola, Florida. He diagnoses and treats gastrointestinal (GI) diseases and disorders in adults. Dr. Newman has clinical interest in caring for adults with celiac disease, Crohn's disease, ulcerative colitis, GI motility disorders, liver disease, cystic fibrosis, inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), gastroesophageal reflux disease (GERD), and pancreatitis.

Dr. Newman is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Colitis, Familial Adenomatous Polyposis, Endoscopy, and Colonoscopy.

Dr. Newman is board certified in The American Board Of Internal Medicine - Gastroenterology and The American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, participating in 9 clinical trials. Dr. Newman is currently accepting new patients.

Graduate Institution

University Of Florida College Of Medicine

Specialties

Gastroenterology

Licenses

Internal Medicine in CA

Board Certifications

The American Board Of Internal Medicine - Gastroenterology
The American Board Of Internal Medicine - Internal Medicine

Fellowships

University of Florida - Jacksonville

Hospital Affiliations

Sacred Heart Hospital
Baptist Hospital
Gulf Breeze Hospital
Ascension Sacred Heart Hospital Emerald Coast
Ascension Sacred Heart Hospital Pensacola

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Gastro Health*
5147 N 9th Ave, Ste 311, Pensacola, FL 32504

Additional Areas of Focus

Dr. Newman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Other
Study Phase: Phase 4
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
Enrollment Status: Completed
Publish Date: April 11, 2025
Intervention Type: Combination product
Study Phase: Not Applicable
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
View 8 Less Clinical Trials
Similar Doctors
Expertise in
56
conditions
Dr. Samer H. Al-Shurieki
Gastroenterology
Expertise in
56
conditions
Dr. Samer H. Al-Shurieki
Gastroenterology
Referral may be required

Gastroenterology Center At Medical Center Clinic - Building 1, Floor 2

8333 N Davis Hwy, 
Pensacola, FL 
 (2.8 miles away)
850-474-8428
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Samer Al-Shurieki is a Gastroenterologist practicing medicine in Pensacola, Florida. Dr. Al-Shurieki is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Lower Esophageal Ring, Benign Esophageal Stricture, Painful Swallowing, Gastrectomy, and Colonoscopy. Dr. Al-Shurieki is currently accepting new patients.

Expertise in
59
conditions
Dr. Mounzer Soued
Gastroenterology
Expertise in
59
conditions
Dr. Mounzer Soued
Gastroenterology
Referral may be required

Gastro Health*

5147 N 9th Ave, Ste 311, 
Pensacola, FL 
 (0.1 miles away)
850-477-2597
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Mounzer Soued, MD, is an independent gastroenterologist at Ascension Sacred Heart in Pensacola, Florida. He diagnoses and treats gastrointestinal (GI) diseases and disorders in adults. Dr. Soued has clinical interest in caring for adults with celiac disease, Crohn's disease, ulcerative colitis, GI motility disorders, liver disease, cystic fibrosis, inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), gastroesophageal reflux disease (GERD), and pancreatitis. Dr. Soued is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Chronic Erosive Gastritis, Gastroesophageal Reflux Disease (GERD), Familial Adenomatous Polyposis, Gastrectomy, and Colonoscopy. Dr. Soued is board certified in The American Board Of Internal Medicine - Gastroenterology. Dr. Soued is currently accepting new patients.

Expertise in
34
conditions
Dr. Ronald S. Powell
Gastroenterology
Expertise in
34
conditions
Dr. Ronald S. Powell
Gastroenterology
Referral may be required

Gastroenterology Center At Medical Center Clinic - Building 1, Floor 2

8333 N Davis Hwy, 
Pensacola, FL 
 (2.8 miles away)
850-474-8428
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ronald Powell is a Gastroenterologist practicing medicine in Pensacola, Florida. Dr. Powell is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Gastric Dysmotility, Painful Swallowing, Swallowing Difficulty, Endoscopy, and Gastrectomy. Dr. Powell is currently accepting new patients.

Frequently Asked Questions about Dr. Frederic B. Newman

How do I make an appointment with Dr. Frederic B. Newman?

You can book an appointment with Dr. Frederic B. Newman by calling their office at 850-477-2597. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Frederic B. Newman a top-rated expert for Viral Gastroenteritis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Frederic B. Newman is classified as an Distinguished expert for Viral Gastroenteritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Frederic B. Newman specialize in?

While Dr. Frederic B. Newman is a Gastroenterology, they have specific expertise in Viral Gastroenteritis, Colitis, and Familial Adenomatous Polyposis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Frederic B. Newman accept my insurance?

Dr. Frederic B. Newman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 850-477-2597 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Newman's expertise for a condition
ConditionClose
    View All 40 Advanced Conditions
    View All 67 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile